JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Intuitive Surgical Inc

Cerrado

SectorSanidad

551.23 4.64

Resumen

Variación precio

24h

Actual

Mínimo

525.35

Máximo

552.26

Métricas clave

By Trading Economics

Ingresos

-40M

664M

Ventas

187M

2.4B

P/B

Media del Sector

62.123

37.461

Margen de beneficios

27.221

Empleados

15,638

EBITDA

268M

987M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+16.06% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-21B

164B

Apertura anterior

546.59

Cierre anterior

551.23

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

127 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Intuitive Surgical Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 oct 2025, 23:55 UTC

Acciones populares

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 oct 2025, 21:14 UTC

Ganancias
Principales Movimientos del Mercado

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 oct 2025, 20:38 UTC

Ganancias

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 jul 2025, 21:13 UTC

Ganancias

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 abr 2025, 20:55 UTC

Ganancias

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

22 oct 2025, 15:42 UTC

Ganancias

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 oct 2025, 12:34 UTC

Ganancias

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 oct 2025, 11:49 UTC

Ganancias

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 oct 2025, 20:08 UTC

Ganancias

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 oct 2025, 20:08 UTC

Ganancias

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 oct 2025, 20:05 UTC

Ganancias

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 oct 2025, 20:05 UTC

Ganancias

Intuitive Surgical 3Q Net $704.4M >ISRG

21 oct 2025, 20:05 UTC

Ganancias

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 oct 2025, 20:05 UTC

Ganancias

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 oct 2025, 20:05 UTC

Ganancias

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 jul 2025, 20:14 UTC

Ganancias

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 jul 2025, 20:13 UTC

Ganancias

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 jul 2025, 20:13 UTC

Ganancias

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Net $658.4M >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 jul 2025, 20:05 UTC

Ganancias

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 abr 2025, 20:13 UTC

Ganancias

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Net $698.4M >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 ene 2025, 21:17 UTC

Ganancias

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

Comparación entre iguales

Cambio de precio

Intuitive Surgical Inc previsión

Precio Objetivo

By TipRanks

16.06% repunte

Estimación a 12 Meses

Media 611.68 USD  16.06%

Máximo 685 USD

Mínimo 440 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Intuitive Surgical Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

20 ratings

16

Comprar

3

Mantener

1

Vender

Puntuación técnica

By Trading Central

514.59 / 539.05Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

127 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat